Patents by Inventor David Lee McKinzie

David Lee McKinzie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kappa selective opioid receptor antagonist
    Patent number: 8173695
    Abstract: A selective kappa opioid receptor antagonist useful for treating ethanol use disorder withdrawal and anxiety, and/or depression, or schizophrenia as independent comorbid conditions.
    Type: Grant
    Filed: April 9, 2010
    Date of Patent: May 8, 2012
    Assignee: Eli Lilly and Company
    Inventors: Nuria Diaz Buezo, David Lee McKinzie, Charles Howard Mitch, Concepcion Pedregal-Tercero
  • KAPPA SELECTIVE OPIOID RECEPTOR ANTAGONIST
    Publication number: 20100197669
    Abstract: A selective kappa opioid receptor antagonist useful for treating ethanol use disorder withdrawal and anxiety, and/or depression, or schizophrenia as independent comorbid conditions.
    Type: Application
    Filed: April 9, 2010
    Publication date: August 5, 2010
    Applicant: ELI LILLY AND COMPANY
    Inventors: Nuria DIAZ BUEZO, Concepcion PEDREGAL-TERCERO, David Lee MCKINZIE, Charles Howard Mitch
  • Kappa selective opioid receptor antagonist
    Patent number: 7709522
    Abstract: A selective kappa opioid receptor antagonist, (S)-3-Fluoro-4-[4-[2-(3,5-dimethylphenyl)pyrrolidin-1-yl-methyl]phenoxy]benzamide or a pharmaceutically acceptable salt thereof, useful for treating ethanol use disorder withdrawal, and anxiety and/or depression, or schizophrenia as independent comorbid conditions.
    Type: Grant
    Filed: January 13, 2009
    Date of Patent: May 4, 2010
    Assignee: Eli Lilly and Company
    Inventors: Nuria Diaz Buezo, Concepcion Pedregal-Tercero, David Lee McKinzie, Charles Howard Mitch
  • KAPPA SELECTIVE OPIOID RECEPTOR ANTAGONIST
    Publication number: 20090186873
    Abstract: A selective kappa opioid receptor antagonist useful for treating ethanol use disorder withdrawal and anxiety, and/or depression, or schizophrenia as independent comorbid conditions.
    Type: Application
    Filed: January 13, 2009
    Publication date: July 23, 2009
    Inventors: Nuria Diaz Buezo, Concepcion Pedregal-Tercero, David Lee McKinzie, Charles Howard Mitch